Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software

Studies have shown that proton pump inhibitors (PPIs) increase the brain burden of amyloid-beta (Aβ) and also create vitamin B12 deficiency. However, these two phenomena have deleterious effect on cognition and Alzheimer's disease (AD). Since the use of PPIs has increased tremendously for the l...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alzheimer's research & therapy 2015-12, Vol.7 (79), p.79-79, Article 79
Hauptverfasser:	Akter, Sanjida, Hassan, Md Rajib, Shahriar, Mohammad, Akter, Nahia, Abbas, Md Golam, Bhuiyan, Mohiuddin Ahmed
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology Adult Alzheimer's disease Anti-Ulcer Agents - pharmacology Care and treatment Cognition - drug effects Diagnosis Dosage and administration Esomeprazole - pharmacology Female Humans Lansoprazole - pharmacology Male Omeprazole - pharmacology Pantoprazole Proton pump inhibitors Proton Pump Inhibitors - pharmacology Rabeprazole - pharmacology Software Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!